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Percutaneous transcatheter mitral valvuloplasty is the indicated treatment of choice for 
symptomatic native mitral valve stenosis, but there have been limited reports of successful 
procedures of balloon valvuloplasty for bioprosthetic mitral valve stenosis. We present a 
case of 62-year-old woman suffering from progressive dyspnea due to bioprosthetic mitral 
valve stenosis.  The measured mean pressure gradient across the mitral valve was 30 
mmHg, and mitral valve area was 0.73 cm2. Redoing mitral replacement was considered 
high risk and refused by the patient.  Percutaneous balloon valvuloplasty was performed 
with an Inoue balloon catheter inflated to 20 mm. The patient’s symptoms immediately 
improved after the procedure without any procedure related complications. The mean 
pressure gradient across the valve decreased to 19 mmHg, and the mitral valve area 
became 1.21cm2 in post procedural echocardiography.  We conducted a literature search 
and identified 26 cases of balloon valvuloplasty for degenerated bioprosthetic valves. Of 
these, 14 cases were bioprosthetic mitral valves and the results were favorable. However, 
more case reports are required to establish a base for future expert recommendation of 
balloon valvuloplasty of prosthetic mitral valve. Balloon valvuloplasty will serve a very niche 
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role in highly selected patients with prosthetic mitral valve stenosis.  






 Percutaneous transcatheter balloon valvuloplasty is a technique which was introduced in 
1982 by Kanji Inoue[1] and eventually became the procedure of choice for most cases of 
native mitral valve stenosis[2]. However, balloon valvuloplasty for degenerated bioprosthetic 
mitral valve is rarely performed. We report a successful case of balloon valvuloplasty in a 
patient with a prosthetic mitral valve stenosis and review the related literatures. 
 
Case Report 
A 62-year-old woman with progressive dyspnea in a New York Heart Association functional 
class III was referred to our hospital for a treatment of bioprosthetic mitral valve stenosis. 
Transthoracic and transesophageal echocardiography revealed severe bioprosthetic mitral 
stenosis with elevated pulmonary artery systolic pressure of 85 mmHg. The measured mean 
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pressure gradient across the mitral valve was 30 mmHg, and mitral valve area calculated by 
pressure half-time was 0.73 cm2 (Figure 1A). There was no thrombus and trivial mitral 
regurgitation on the echocardiography.  
The patient had a history of coronary artery bypass graft surgery with a left internal 
mammary artery graft to the left anterior descending artery and 2 saphenous vein grafts to 
the distal right coronary and second marginal coronary arterial segments 9 years ago. 
Subsequently, the patient had undergone mitral valve replacement with a 23 mm 
Carpentier-Edwards bioprosthesis for mitral regurgitation, and aortic valve replacement with 
a 19 mm Carpentier-Edwards bioprosthesis for aortic stenosis 4 years ago. The patient 
suffered a gangrenous right foot and required amputation 1 month ago, and the wound 
healing was delayed. Just after the amputation, the patient developed congestive heart 
failure due to severe bioprosthetic mitral valve stenosis that was resistant to medical 
treatments. Redo mitral valve replacement was required, but the Society of Thoracic 
surgeons (STS) score predicted a 32.0% risk of death for redo surgery. The patient rejected 
open surgery and consented to percutaneous balloon valvuloplasty.  
Right heart catheterization showed that the pulmonary capillary wedge pressure was 39 
mmHg, and the mean pulmonary artery pressure was 55 mmHg. Balloon valvuloplasty was 
performed as previously described with sequential inflations from 17mm to 20mm with a 
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20-mm Inoue balloon (Figure 2). After the balloon valvuloplasty, the pulmonary capillary 
wedge pressure decreased to 29 mmHg, and the mean pulmonary artery pressure 
decreased to 41 mmHg. Cardiac index increased from 1.5 l/min/m2 to 2.0 l/min/m2. The 
hemodynamic findings immediately before and after valvuloplasty are shown in Table 1. 
Transthoracic echocardiography which was performed two days later showed that the mean 
pressure gradient across the mitral valve reduced to 19 mmHg, and mitral valve area 
increased to 1.21 cm2 with trivial mitral regurgitation (Figure 1B). The patient’s symptoms 
improved and exercise capacity increased immediately. There was no complication 




 Percutaneous transcatheter balloon valvuloplasty was first performed in 1982 by Kanji 
Inoue who is the main operator of the present case and also the author of the present 
report[1]. After proving its clinical efficacy in several data, percutaneous mitral valvuloplasty 
has now become the indicated treatment in criterion-suitable cases of native mitral valve 
stenosis[2]. Balloon valvuloplasty for other valves including aortic, tricuspid, pulmonary 
valve have also been performed in well selected patients with favorable outcomes[3]. In 
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particular, balloon aortic valvuloplasty is currently being applied more frequently 
compared to the past with the advent of transcatheter aortic valve replacement[4, 5]. 
However, the reports regarding balloon valvuloplasty for bioprosthetic valve failure in adult 
patients are extremely limited. A literature search identified 26 cases of balloon valvuloplasty 
for degenerated bioprosthetic valve; 14 cases in mitral position[6–16], 6 cases in aortic 
position[17, 18, 16, 19, 20], 4 cases in tricuspid position[21–24], and 2 case in pulmonary 
position(Table 2)[25][16]. The valvuloplasty for degenerative bioprosthesis in aortic position 
showed poorer outcomes; 2 patients died after the procedure and 2 patient required surgical 
valve replacement[17, 19, 16]. Valvuloplasty for bioprosthetic valve stenosis in other 
positions showed more favorable outcome. After balloon valvuloplasty, symptoms of almost 
all patients improved. One patient after balloon valvuloplasty for prosthetic mitral valve 
developed a moderate mitral regurgitation at 6 month follow-up and a cusp rupture at 12 
month[16]. Although no major procedure related complications were reported except for this 
patient, several authors have warned against performing valvuloplasty of bioprosthetic mitral 
valve[26]. The dysfunction or obstruction of prosthetic valve usually results from pannus 
ingrowth, leaflet calcification, thrombosis or vegetation. In vitro studies suggest that the 
increased mitral valve area attained from balloon valvuloplasty results from balloon induced 
leaflet tearing, calcium fractures, and cusp perforation[27]. We cannot draw any concrete 
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conclusions from these limited experiences, more case reports are needed to establish a 
base for future expert recommendation of balloon valvuloplasty of prosthetic mitral valve.  
Recently, the transcatheter valve-in-valve technique is emerging as a therapeutic option for 
patients with failure of previously implanted bioprosthetic valve[28, 29]. After receiving the 
favorable results for bioprosthetic aortic valve, the valve-in-valve technique for bioprosthetic 
mitral valve has been applied using the transapical approach and expected to become a 
complementary approach to redo mitral valve replacement. Although the valve-in-valve 
technique seems hopeful, the Ministry of Health, Labor and Welfare has not approved the 
valve-in-valve procedure for mitral valve in Japan. When compared to the valve-in-valve 
technique, the main advantage of balloon valvuloplasty is the less invasive percutaneous 
approach, omitting the need for apical incision and general anesthesia.  
In conclusion, the present report demonstrates the successful use of percutaneous 
transcatheter balloon valvuloplasty for bioprosthetic mitral valve stenosis. Balloon 
valvuloplasty for prosthetic mitral valve shows favorable outcomes in limited case reports. 
However, there are other opinions that warned against performing valvuloplasty for 
prosthetic mitral valve since the balloon valvuloplasty inevitable induce leaflet tearing, 
calcium fractures, and cusp perforation. More evidences are required to establish a concrete 
recommendation for balloon valvuloplasty for bioprosthetic mitral valve. Balloon 
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valvuloplasty will serve a very niche role in highly selected patients with prosthetic mitral 
valve stenosis who is at high risk for redo mitral valve replacement and valve-in-valve 
procedure.   
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Figure 1. A, Parasternal long axis view showing degenerated bioprosthesis mitral valve with 
trivial mitral regurgitation. B, Before the balloon valvuloplasty, mitral valve area was 0.73 
cm2, and mean pressure gradient was 30 mmHg. C,  After the balloon valvuloplasty, 
parasternal long axis view shows no worsening of mitral regurgitation. D,  
The mitral valve area increased to 1.21 cm2, and mean pressure gradient decreased to 19 
mmHg. 
Figure 2. A, Fluoroscopic image demonstrating the Inoue balloon passing through the 
stenotic bioprosthetic valve. B, Balloon valvuloplasty was performed with the Inoue balloon 




Tabel 2. Reports of balloon valvuloplasty in bioprosthesis 
 














Calvo et al (1987) [6] 29 M Mitral 10 15 11 Trefoil 25mm Mild MR 
Calvo et al (1987) [6] 37 F Mitral 3 13 3 Trefoil 25mm None 
Arie et al (1989) [7] 62 F Mitral 13 13 8 Mansfield 20mm None 
Cox et al (1989) [8] 53 F Mitral 13 11 6 Cook 23mm Mild MR, Restenosis 
Fernandez et al (1990) [9] 62 F Mitral 10 22 6 Mansfield 20mm None 
Spellburg et al (1991) [10] 64 F Mitral 8 30 10 Mansfield 18mm Atrial shunt 
Babic et al (1991) [11] 34 M Mitral 3 29 9 Mansfield 25mm None 
Orbe et al (1991) [16] N/A Mitral 10 15 11 Trefoil 25mm Severe MR 
Orbe et al (1991) [16] N/A Mitral 3 13 3 Trefoil 25mm None 
Orbe et al (1991) [16] N/A Mital 7 16 5 Monoballoon 25mm None 
Lip et al (1997) [12]   29 F Mitral 6 12 2~4 Inoue 28mm None 
Ludman et al (1999) [13] 54 F Mitral 9 N/A N/A Inoue N/A None 
Hurst et al (2004) [14] 78 M Mitral 1.5 14 11 Inoue 26mm None 
Bekeredjian et al (2010) [15] 86 F Mitral 9 9 5 Inoue 26mm None 
Mckay et al (1988) [17] 28 M Aortic 6 57 41 Mansfield 20mm Surgical Replacement 
Mckay et al (1988) [17] 31 F Aortic 10 81 38 Mansfield 15mm Death 
Ramondo et al (1989) [18] 60 M Aortic 6 110 25 Schneider 18mm None  
Orbe et al (1991) [16] N/A Aortic 8 60 40 N/A Surgical Replacement  
Kirwan et al (2004) [19] 79 M Aortic 18 80 45 N/A 15mm Death due to Acute AR 
Dejam et al (2011) [20] 90 F Aortic 15 55 36 Diamond 14mm Restenosis in 8 months 
Feit et al (1986) [21] 46 M Tricuspid 10 22 15 Meditech 20 None 
Wren et al (1989) [22] 19 F Tricuspid 13 8~10 4~6 Mansfield 20mm Restenosis in 3 months 
Chow et al (1990) [23] 67 F Tricuspid 7 6 2.5 Cook 23mm None 
Yunoki et al (2006) [24] 59 F Tricuspid 22 14 6 N/A 25mm None 
Orbe et al (1991) [16] N/A Pulmonary 12 70 50 N/A None 
Oomman et al (2004) [25] 20 M Pulmonary 9 100 50 Inoue 20mm None 
PG, pressure gradient, MR, mitral regurgitation, AR, aortic regurgitation, N/A, not available 
Table 1. Hemodynamic data before and after the balloon valvuloplasty 
 
Hemodynamic Findings Before  After 
Heart Rate  80 75 
Pressure (mmHg)   
  Mean Pulmonary Capillary Wedge 39 29 
  Pulmonary Artery (mean) 88/39 (55) 70/27 (41) 
  Right Ventricle 82/11 51/9 
  Mean Right Atrium  17 15 
Cardiac Index (l/m/m2) 1.5 2.0 
 
 
